Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights

View through CrossRef
Epilepsy affects ~50 million people. In ~30% of patients the etiology is unknown, and ~30% are unresponsive to anti-epileptic drugs. Intractable epilepsy often leads to multiple seizures daily or weekly, lasting for years, and accompanied by cognitive, behavioral, and psychiatric problems. This multidisciplinary scientific (not clinical) ‘Perspective’ article discusses Autoimmune Epilepsy from immunological, neurological and basic-science angles. The article includes summaries and novel discoveries, ideas, insights and recommendations. We summarize the characteristic features of the respective antigens, and the pathological activityin vitroand in animal models of autoimmune antibodies to: Glutamate/AMPA-GluR3, Glutamate/NMDA-NR1, Glutamate/NMDA-NR2, GAD-65, GABA-R, GLY-R, VGKC, LGI1, CASPR2, and β2 GP1, found in subpopulations of epilepsy patients. Glutamate receptor antibodies: AMPA-GluR3Bpeptide antibodies, seem so far as the most exclusive and pathogenic autoimmune antibodies in Autoimmune Epilepsy. They kill neural cells by three mechanisms: excitotoxicity, Reactive-Oxygen-Species, and complement-fixation, and induce and/or facilitate brain damage, seizures, and behavioral impairments. In this article we raise and discuss many more topics and new insights related to Autoimmune Epilepsy. 1. Few autoimmune antibodies tilt the balance between excitatory Glutamate and inhibitory GABA, thereby promoting neuropathology and epilepsy; 2. Many autoantigens are synaptic, and have extracellular domains. These features increase the likelihood of autoimmunity against them, and the ease with which autoimmune antibodies can reach and harm these self-proteins. 3. Several autoantigens have ‘frenetic character’- undergoing dynamic changes that can increase their antigenicity; 4. The mRNAs of the autoantigens are widely expressed in multiple organs outside the brain. If translated by default to proteins, broad spectrum detrimental autoimmunity is expected; 5. The autoimmunity can precede seizures, cause them, and be detrimental whether primary or epiphenomenon; 6. Some autoimmune antibodies induce, and associate with, cognitive, behavioral and psychiatric impairments; 7. There are evidences for epitope spreading in Autoimmune Epilepsy; 8. T cells have different ‘faces’ in the brain, and in Autoimmune Epilepsy: Normal T cells are needed for the healthy brain. Normal T cells are damaged by autoimmune antibodies to Glutamate/AMPA GluR3, which they express, and maybe by additional autoantibodies to: Dopamine-R, GABA-R, Ach-R, Serotonin-R, and Adrenergic-R, present in various neurological diseases (summarized herein), since T cells express all these Neurotransmitter receptors. However, autoimmune and/or cytotoxic T cells damage the brain; 9. The HLA molecules are important for normal brain function. The HLA haplotype can confer susceptibility or protection from Autoimmune Epilepsy; 10. There are several therapeutic strategies for Autoimmune Epilepsy.
Title: Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights
Description:
Epilepsy affects ~50 million people.
In ~30% of patients the etiology is unknown, and ~30% are unresponsive to anti-epileptic drugs.
Intractable epilepsy often leads to multiple seizures daily or weekly, lasting for years, and accompanied by cognitive, behavioral, and psychiatric problems.
This multidisciplinary scientific (not clinical) ‘Perspective’ article discusses Autoimmune Epilepsy from immunological, neurological and basic-science angles.
The article includes summaries and novel discoveries, ideas, insights and recommendations.
We summarize the characteristic features of the respective antigens, and the pathological activityin vitroand in animal models of autoimmune antibodies to: Glutamate/AMPA-GluR3, Glutamate/NMDA-NR1, Glutamate/NMDA-NR2, GAD-65, GABA-R, GLY-R, VGKC, LGI1, CASPR2, and β2 GP1, found in subpopulations of epilepsy patients.
Glutamate receptor antibodies: AMPA-GluR3Bpeptide antibodies, seem so far as the most exclusive and pathogenic autoimmune antibodies in Autoimmune Epilepsy.
They kill neural cells by three mechanisms: excitotoxicity, Reactive-Oxygen-Species, and complement-fixation, and induce and/or facilitate brain damage, seizures, and behavioral impairments.
In this article we raise and discuss many more topics and new insights related to Autoimmune Epilepsy.
1.
Few autoimmune antibodies tilt the balance between excitatory Glutamate and inhibitory GABA, thereby promoting neuropathology and epilepsy; 2.
Many autoantigens are synaptic, and have extracellular domains.
These features increase the likelihood of autoimmunity against them, and the ease with which autoimmune antibodies can reach and harm these self-proteins.
3.
Several autoantigens have ‘frenetic character’- undergoing dynamic changes that can increase their antigenicity; 4.
The mRNAs of the autoantigens are widely expressed in multiple organs outside the brain.
If translated by default to proteins, broad spectrum detrimental autoimmunity is expected; 5.
The autoimmunity can precede seizures, cause them, and be detrimental whether primary or epiphenomenon; 6.
Some autoimmune antibodies induce, and associate with, cognitive, behavioral and psychiatric impairments; 7.
There are evidences for epitope spreading in Autoimmune Epilepsy; 8.
T cells have different ‘faces’ in the brain, and in Autoimmune Epilepsy: Normal T cells are needed for the healthy brain.
Normal T cells are damaged by autoimmune antibodies to Glutamate/AMPA GluR3, which they express, and maybe by additional autoantibodies to: Dopamine-R, GABA-R, Ach-R, Serotonin-R, and Adrenergic-R, present in various neurological diseases (summarized herein), since T cells express all these Neurotransmitter receptors.
However, autoimmune and/or cytotoxic T cells damage the brain; 9.
The HLA molecules are important for normal brain function.
The HLA haplotype can confer susceptibility or protection from Autoimmune Epilepsy; 10.
There are several therapeutic strategies for Autoimmune Epilepsy.

Related Results

Portrait of Epilepsy on the Canvas of Global Health
Portrait of Epilepsy on the Canvas of Global Health
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. GBD Epilepsy Collabora...
Neuropathology in the North American sudden unexpected death in epilepsy registry
Neuropathology in the North American sudden unexpected death in epilepsy registry
Abstract Sudden unexpected death in epilepsy is the leading category of epilepsy-related death and the underlying mechanisms are incompletely understood. Risk factor...
River Epilepsy—A Preventable Form of Epilepsy
River Epilepsy—A Preventable Form of Epilepsy
Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan: A 3-Year Longitudinal, Prospective, Population-Based Study. ...
Application of the APE2-CHN and RITE2-CHN scores for autoimmune epilepsy in Chinese patients: a retrospective study
Application of the APE2-CHN and RITE2-CHN scores for autoimmune epilepsy in Chinese patients: a retrospective study
Abstract Background : Autoimmune epilepsy is recognized as a distinct entity of epilepsy with underestimated incidence. Our previous study reported that prompt diagnosis an...
The pattern of knowledge, attitude, and practice of epilepsy in Bengali-speaking literate epilepsy patients in Kolkata
The pattern of knowledge, attitude, and practice of epilepsy in Bengali-speaking literate epilepsy patients in Kolkata
Background: A good knowledge, attitude, and practice (KAP) are lacking among epilepsy patients and the general public (even literates) across the world. As a result, a treatment ga...
Factors affecting employment status in people with epilepsy
Factors affecting employment status in people with epilepsy
Aim: People with epilepsy often face difficulties finding and keeping a job in India. This study aimed to determine the employment rate of people with epilepsy, compare it with tha...

Back to Top